FDA Warns Cosmetics Firm on Unapproved, Misbranded Drugs
The Food and Drug Administration has issued a warning letter to Lifetech Resources LLC regarding its manufacturing, distribution, and promotion of RapidLash Eyelash Renewal Serum, NeuLash Active Eyelash Technology, and NeuveauBrow Active Eyebrow Technology, which FDA states are unapproved and…
Sign up for a free preview to unlock the rest of this article
Export Compliance Daily combines U.S. export control news, foreign border import regulation and policy developments into a single daily information service that reliably informs its trade professional readers about important current issues affecting their operations.
misbranded drugs and violate provisions of the Federal Food, Drug, and Cosmetic Act. FDA urges LifeTech to take prompt action to correct the violations, and states that failure to promptly correct the violations may result in legal action, including seizure and injunction.